{"id":"https://openalex.org/W4361971675","doi":"https://doi.org/10.1158/0008-5472.22428363","title":"Supplementary Materials from Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes","display_name":"Supplementary Materials from Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361971675","doi":"https://doi.org/10.1158/0008-5472.22428363"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22428363","doi":"https://doi.org/10.1158/0008-5472.22428363","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22428363","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_from_Targeting_Pyruvate_Kinase_M2_Phosphorylation_Reverses_Aggressive_Cancer_Phenotypes/22428363/1/files/39874689.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_from_Targeting_Pyruvate_Kinase_M2_Phosphorylation_Reverses_Aggressive_Cancer_Phenotypes/22428363/1/files/39874689.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084933211","display_name":"Maria Apostolidi","orcid":"https://orcid.org/0000-0002-5506-2028","observed_orcids":["https://orcid.org/0000-0002-5506-2028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Apostolidi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5506-2028","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003079520","display_name":"Ioannis A. Vathiotis","orcid":"https://orcid.org/0000-0003-3467-7629","observed_orcids":["https://orcid.org/0000-0003-3467-7629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ioannis A. Vathiotis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3467-7629","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000564930","display_name":"Viswanathan Muthusamy","orcid":"https://orcid.org/0000-0003-2449-6154","observed_orcids":["https://orcid.org/0000-0003-2449-6154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viswanathan Muthusamy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017110695","display_name":"Patricia Gaule","orcid":"https://orcid.org/0000-0002-3075-7392","observed_orcids":["https://orcid.org/0000-0002-3075-7392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Gaule","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085901310","display_name":"Brandon M. Gassaway","orcid":"https://orcid.org/0000-0002-6102-2356","observed_orcids":["https://orcid.org/0000-0002-6102-2356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brandon M. Gassaway","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6102-2356","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5820-4397","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067568281","display_name":"Jesse Rinehart","orcid":"https://orcid.org/0000-0003-4839-4005","observed_orcids":["https://orcid.org/0000-0003-4839-4005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jesse Rinehart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12915","display_name":"Biochemical Acid Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pkm2","display_name":"PKM2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tumor-aggressiveness","display_name":"tumor aggressiveness","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.4690000116825104},{"id":"https://openalex.org/keywords/cancer-phenotypes","display_name":"cancer phenotypes","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5269480347633362},{"id":"https://openalex.org/C2780854706","wikidata":"https://www.wikidata.org/wiki/Q900970","display_name":"Pyruvate kinase","level":4,"score":0.49986767768859863},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.49689510464668274},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.481080025434494},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.46030476689338684},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35537347197532654},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.324653685092926},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2826045751571655},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2676769495010376},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23661324381828308},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.18906211853027344},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16719672083854675},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.1390095353126526}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22428363","doi":"https://doi.org/10.1158/0008-5472.22428363","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22428363","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_from_Targeting_Pyruvate_Kinase_M2_Phosphorylation_Reverses_Aggressive_Cancer_Phenotypes/22428363/1/files/39874689.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22428363.v1","doi":"https://doi.org/10.1158/0008-5472.22428363.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22428363.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22428363","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Materials_from_Targeting_Pyruvate_Kinase_M2_Phosphorylation_Reverses_Aggressive_Cancer_Phenotypes/22428363","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22428363","doi":"https://doi.org/10.1158/0008-5472.22428363","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22428363","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_from_Targeting_Pyruvate_Kinase_M2_Phosphorylation_Reverses_Aggressive_Cancer_Phenotypes/22428363/1/files/39874689.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.7246000170707703,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361971675.pdf","grobid_xml":"https://content.openalex.org/works/W4361971675.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1989790390","https://openalex.org/W2080752012","https://openalex.org/W2163266294","https://openalex.org/W2261521410","https://openalex.org/W2808325313","https://openalex.org/W2992689798","https://openalex.org/W3080784277"],"related_works":["https://openalex.org/W4362164209","https://openalex.org/W4361878409","https://openalex.org/W4361899800","https://openalex.org/W4361899819","https://openalex.org/W4361972290","https://openalex.org/W6986666204","https://openalex.org/W7061746811","https://openalex.org/W2601568647","https://openalex.org/W3142779309","https://openalex.org/W2020627647"],"abstract_inverted_index":{"This":[0],"PDF":[1],"file":[2],"includes:":[3],"Supplementary":[4,8,11],"Materials":[5],"and":[6,10],"Methods,":[7],"Figures":[9],"Tables":[12]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}